OR WAIT null SECS
July 18, 2022
The European Medicines Agency guidance highlights key principles and examples of good practices to prevent and manage shortages of human medicines.
Vertex’s $320 million acquisition of ViaCyte will give the company complementary capabilities for its Type 1 diabetes therapy program.
July 14, 2022
Application for OTC contraceptive highlights efforts to broaden access to medicines.
July 13, 2022
WHO’s Science Council released a report calling for a collective effort to accelerate global access to genomics.
Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.
July 12, 2022
Wacker is investing more than €100 million (US$100.5 million) to expand its Halle, Germany, site with an mRNA competence center.
July 08, 2022
Coya Therapeutics has secured intellectual property rights to the research, development, and manufacturing of exosome-polymer hybrids.
Bio-Rad’s CFX Opus Deepwell Real-Time PCR Detection System is designed to support researchers in developing nucleic acid detection assays.
Bio-Rad’s EconoFit Chromatography Column Packs support resin screening experiments in the development of protein purification workflows.